Literature DB >> 23751848

Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.

Joon Suk Kim1, Won Kim, Young Ho So, Su Jong Yu, Byeong Gwan Kim.   

Abstract

BACKGROUND: Radiofrequency ablation (RFA) is an efficient and safe treatment modality for early-stage hepatocellular carcinoma (HCC). However, its application is sometimes limited by several topographical factors. Whether topographical characteristics are risk factors for local recurrence after RFA is still under debate. GOALS: The aims of this study were to identify topographical risk factors for the local recurrence of solitary HCC after RFA and to evaluate their impact on long-term treatment outcomes.
METHODS: The clinical and radiologic findings of patients with solitary hepatitis B virus (HBV)-related HCC<4.0 cm undergoing RFA were retrospectively reviewed. The Cox regression model was used to identify risk factors that predicted local recurrence.
RESULTS: A total of 300 patients with solitary, HBV-related HCC were included in this retrospective cohort study. Seventy patients (23.3%) experienced local recurrence after RFA during the median follow-up duration of 43.0 months (range, 3.0 to 69.0 mo). Multivariate analysis showed that tumor size ≥2.0 cm [hazard ratio (HR), 1.716; P=0.047], proximity to a large vessel (HR, 2.609; P=0.024), and proximity to the diaphragm (HR, 3.128; P=0.004) were independent predictors of the local recurrence of solitary HCC. Moreover, the cumulative risk of local recurrence after RFA increased with the number of risk factors.
CONCLUSIONS: Proximity of HCC to a large vessel or the diaphragm as well as large tumor size may increase the risk of local recurrence after RFA. Therefore, the topographical factors of HCC should be considered to tailor therapeutic decisions for solitary, HBV-related HCC.

Entities:  

Mesh:

Year:  2014        PMID: 23751848     DOI: 10.1097/MCG.0b013e318294521f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

1.  Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma.

Authors:  Angelo Della Corte; Claudio Sallemi; Francesca Ratti; Lorenzo Monfardini; Simone Gusmini; Federica Cipriani; Renato Pennella; Domenico Santangelo; Valentina Burgio; Andrea Casadei-Gardini; Luca Aldrighetti; Francesco De Cobelli
Journal:  Cardiovasc Intervent Radiol       Date:  2022-09-30       Impact factor: 2.797

Review 2.  Prognostic factors for hepatocellular carcinoma recurrence.

Authors:  Antonio Colecchia; Ramona Schiumerini; Alessandro Cucchetti; Matteo Cescon; Martina Taddia; Giovanni Marasco; Davide Festi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

3.  Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.

Authors:  Chao An; Wang-Zhong Li; Zhi-Mei Huang; Xiao-Ling Yu; Yu-Zhi Han; Fang-Yi Liu; Song-Song Wu; Jie Yu; Ping Liang; Jinhua Huang
Journal:  Eur Radiol       Date:  2021-01-05       Impact factor: 5.315

4.  Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.

Authors:  Ju-Yeon Cho; Moon Seok Choi; Gil Sun Lee; Won Sohn; Jemma Ahn; Dong-Hyun Sinn; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  Clin Mol Hepatol       Date:  2016-12-25

5.  The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses.

Authors:  Xueqin Chen; Fan Wu; Yanmei Liu; Jiao Lou; Beibei Zhu; Li Zou; Wei Chen; Jing Gong; Ying Wang; Rong Zhong
Journal:  Oncotarget       Date:  2016-08-02

6.  Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma.

Authors:  Bin Liang; Siyang Yao; Jiapeng Zhou; Zongkui Li; Tianqi Liu
Journal:  J Hepatocell Carcinoma       Date:  2018-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.